SCHEMBL24315968

SCHEMBL24315968

O=C1Nc2ccnc3c(C4CCN(Cc5ccccc5)CC4)ccc1c23

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.43
IKZF2 Q9UKS7 3/20 0.43
USP30 Q70CQ3 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
OPRM1 P35372 2/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
RECQL P46063 1/20 0.40
ACHE P22303 3/20 0.40
HPGDS O60760 1/20 0.40
DRD2 P14416 3/20 0.39
DRD4 P21917 2/20 0.39
DRD3 P35462 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24316091 0.90 HRH3 (0.38) PARP1USP30MEN1KMT2ACYP3A4
SCHEMBL24315934 0.81 DRD2 (0.49) DRD2DRD4DRD3
SCHEMBL24315958 0.78 SIGMAR1 (0.40) PARP1MEN1KMT2AOPRM1OPRK1
SCHEMBL24315966 0.77 CDK2 (0.37)
SCHEMBL29611199 0.76 IKZF2 (0.57) IKZF2OPRM1
SCHEMBL24315901 0.76 IKZF2 (0.57) IKZF2OPRM1
SCHEMBL26661983 0.74 KDM4E (0.31)
SCHEMBL24315938 0.73 KDM4E (0.44) HPGDS
SCHEMBL26657288 0.71 IKZF2 (0.42) IKZF2MEN1KMT2AOPRM1OPRK1
SCHEMBL29774566 0.69 PARP1 (0.48) PARP1MEN1KMT2ADRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed